Hospital materials management and pharmacy stores

In short

Hospital materials management is the planning, procurement, storage, distribution and disposal of every consumable and durable item a hospital uses — drugs, surgical consumables, implants, reagents, linen, stationery and equipment spares — so that the right item is available at the right place, time, quantity, quality and cost. Drugs and consumables alone absorb roughly 25-40% of a hospital's recurring expenditure in Indian hospitals, second only to salaries, so it is the biggest controllable cost centre an administrator owns. The pharmacy store is its most regulated node, governed by the Drugs and Cosmetics Act, 1940 and Rules, 1945, the NDPS Act, 1985 and NABH's Medication Management (MOM) chapter. It is examined in BHA/BBA hospital management papers (hospital operations, materials and inventory management), in MHA entrance and placement tests, and is a standard interview area for roles in hospital purchase, stores, pharmacy operations and quality.

Explained

Scope, objectives and organisation

• Definition: materials management is an integrated function covering the "5 Rs" — right quality, right quantity, right time, right source, right price — across the material cycle.
• Cycle: need identification → specification/standardisation → budgeting → purchase → receipt and inspection → storage → issue/distribution → use → condemnation and disposal.
• Objectives: continuous availability (zero stock-out of life-saving items), lowest total cost of ownership, minimum capital locked in inventory, quality assurance, prevention of pilferage, expiry and obsolescence.
• Typical structure: Materials Manager → purchase section, central/general store, pharmacy store, condemnation cell; sub-stores in wards, OT, ICU, labs and CSSD. Pharmacy usually reports functionally to a Chief Pharmacist/Pharmacy Manager with a registered pharmacist in charge.
• Key committees: Purchase/Tender Committee (specification, vendor selection), Pharmacy and Therapeutics Committee (PTC) (formulary, drug addition/deletion, ADR review, antibiotic policy), Condemnation Board, Infection Control Committee (consumable and disinfectant choice).
• Centralisation vs decentralisation: central purchase gives volume discount and uniform specification; decentralised sub-stores give responsiveness. Most Indian hospitals use central purchase + decentralised issue with imprest (fixed par-level) ward stocks.

Procurement: methods, documents and Indian practice

• Specification and standardisation: drugs purchased by generic name and strength, not brand; consumables by material, size, sterility and IS/ISO reference. Standardisation reduces variety and dead stock.
• Modes of purchase: open/advertised tender, limited tender, single tender (proprietary item, with justification), rate contract, direct/spot purchase (petty, emergency), local purchase against indent, and e-procurement.
• Rate contract: price, specification and terms fixed with a supplier for a period (usually 1-2 years); hospital places supply orders as needed — no repeated tendering, no stock holding by the hospital. Used widely by state medical services corporations.
• GeM (Government e-Marketplace) is the default route for government hospitals; large state procurement runs through corporations such as TNMSC (Tamil Nadu), KSMSCL (Kerala), RMSCL (Rajasthan) and CMSS/HLL at the central level. The two-bid (technical + financial) system is standard for high-value items.
• Documents: indent/requisition → purchase requisition → NIT/tender → comparative statement → purchase order (PO) → invoice and challan → goods received note (GRN) → inspection report → stock ledger/bin card → issue voucher → payment.
• Vendor evaluation: manufacturing licence and WHO-GMP, drug licence, product sample and batch test, past performance, delivery lead time, credit terms, after-sales service for equipment, blacklisting history.
• Commercial terms examined: earnest money deposit (EMD), security/performance deposit, liquidated damages for late supply, warranty and comprehensive AMC, buy-back, turnkey purchase, and GST — after the rate reform in force since 22 September 2025 (5%/18% with a 40% demerit rate), medicines mostly attract 5% with a list of lifesaving drugs at nil, and most medical devices, apparatus and consumables were also brought down to 5% (rates are notified and do change; verify the current notification for a specific item). Healthcare services are exempt, so hospitals generally cannot take input tax credit — GST is a real cost in purchase comparison.
• Capital equipment purchase additionally needs life-cycle costing: price + installation + consumables + spares + AMC + training + disposal, and AERB licensing for X-ray/CT/radiotherapy.

Inventory control techniques

• Need: a hospital may stock 1,000-5,000 line items; uniform control is wasteful, so items are classified and controlled selectively.
• ABC analysis (Always Better Control) — by annual consumption value: A ≈ 10% of items, 70% of value; B ≈ 20% of items, 20% of value; C ≈ 70% of items, 10% of value. A items get tight control, frequent review, low safety stock; C items get bulk buying and loose control. (Boundaries are conventions, not fixed law.)
• VED analysis — by criticality: Vital (death or serious harm if absent — adrenaline, oxygen, anti-snake venom, blood), Essential (treatment suffers), Desirable (minor effect). Vital items get safety stock regardless of cost.
• ABC-VED matrix (coupling): cells AV, BV, CV, AE, AD form Category I (administrator/top management control), BE, CE, BD → Category II (middle management), CD → Category III (store-keeper level). Standard exam question.
• Other classifications: FSN/FNS (Fast, Slow, Non-moving — by issue frequency; identifies dead stock), SDE (Scarce, Difficult, Easy to obtain — drives lead time and buffer), HML (High, Medium, Low unit price — controls pilferage), XYZ (by value of stock *in hand* — used at stock-taking), SOS (Seasonal/Off-seasonal), GOLF (Government, Ordinary, Local, Foreign source).
• Review systems: fixed-order-quantity (Q-system) — order EOQ when stock hits reorder level; fixed-period (P-system) — review at fixed intervals and top up to a maximum; two-bin system — issue from bin 1, reorder when it empties (used for C items, ward consumables); just-in-time / vendor-managed inventory for high-value implants and reagents (consignment stock paid on use); imprest/par-level for ward and OT stocks.
• Stock levels: safety (buffer) stock, reorder level, minimum, maximum, danger level. Lead time = time from indent to usable stock in store (includes inspection).
• Store performance indicators: inventory turnover ratio, stock-out rate, expiry/wastage as % of purchase value, inventory holding (carrying) cost, number of emergency purchases, vendor on-time delivery %, indent-to-issue turnaround.

Storage: central store and drug store design

• Siting: ground floor, near service entry with level access for trucks, away from public traffic, linked by lift/trolley route to wards, OT, pharmacy; separate receiving and issuing bays to avoid crossover.
• Layout and practice: bin/rack storage with bin cards, alphabetical or therapeutic-class arrangement, pallets off the floor, 15-20 cm clearance from wall, fire extinguishers and sprinkler clearance, pest and rodent control, no food storage.
• FEFO (First Expiry First Out) is the rule for drugs — it overrides plain FIFO, because batch received later may expire earlier. Near-expiry items (usually 3-6 months) are flagged, segregated and returned to supplier where the PO permits.
• Cold chain: vaccines and biologicals at +2 to +8 °C in ILR/pharmacy refrigerators, some at −15 to −25 °C (deep freezer); twice-daily temperature logs, min-max thermometer or data logger, dedicated circuit with power back-up, no vaccines in door shelves, cold boxes and conditioned ice packs for transport, VVM (vaccine vial monitor) reading before use.
• Special storage areas: narcotics in a double-locked substantial safe/almirah, keys with the registered pharmacist, separate NDPS register with running balance; flammables and alcohol in a separate ventilated store; cytotoxics segregated with spill kit; LASA (look-alike sound-alike) drugs physically separated and tallboy-labelled; high-alert drugs (concentrated KCl, insulin, heparin, neuromuscular blockers) in a demarcated area with a double-check rule; medical gases — cylinders upright, chained, full and empty separated, colour coded (oxygen black body/white shoulder, nitrous oxide blue, medical air black with white-and-black shoulders per the Indian standard for gas cylinder identification).
• Documentation: stock/bin cards, stock ledger, GRN register, issue vouchers, expiry register, temperature log, breakage/pilferage register, condemnation file. Perpetual inventory plus periodic physical verification; discrepancy reconciled and certified.

Pharmacy operations and distribution

• Types: outpatient pharmacy (retail-like, cash/insurance billing), inpatient/ward pharmacy, satellite pharmacies (OT, ICU, emergency), 24×7 emergency pharmacy, bulk drug store, manufacturing/compounding and IV admixture unit (where licensed), and a central sterile injectable/TPN unit in large hospitals.
• Drug distribution systems:
  1. Floor/ward stock — bulk stock in ward; fast but high loss, expiry and error risk.
  2. Individual prescription order — dispensed patient-wise on indent; good control, more pharmacist time.
  3. Unit dose dispensing (UDD) — each dose packed, labelled and supplied for 24 hours; lowest medication error and wastage, highest control, needs staff and software.
  4. Combination (UDD + small floor stock of emergency drugs) — commonest practical model.
  5. Automated dispensing cabinets / robotic dispensing in large corporate hospitals.
• Formulary: the PTC-approved list of drugs the hospital will stock, by generic name, with strengths, restrictions and antibiotic policy; built on the National List of Essential Medicines (NLEM) — the latest revision widely in use is NLEM 2022 with around 384 medicines (check for a newer revision) — and the WHO Model List.
• Crash cart and emergency tray: standard sealed contents list, checked each shift, resealed after use, expiry-tracked.
• Returns, recalls and disposal: patient/ward returns inspected before restocking; recall procedure traces batch number to patient through the dispensing record (a NABH requirement); expired and date-expired drugs quarantined in a red "not for use" area and destroyed as per rules — expired cytotoxics and most expired medicines are handled as Category/Yellow-bag waste under the Bio-Medical Waste Management Rules, 2016 (as amended), returned to manufacturer or sent to the common facility, never to municipal waste.
• Pharmacy informatics: HIS/ERP modules for indent, dispensing, batch and expiry tracking, barcode scanning, auto-reorder, drug-interaction alerts and consumption analytics; e-prescription linkage. Billing integration prevents the common "issued but not billed" leakage.

Legal and accreditation framework (India)

• Drugs and Cosmetics Act, 1940 and Rules, 1945: licensing of sale premises — Form 20/21 (retail) and Form 20B/21B (wholesale) issued on Forms 19/19A applications by the State Drugs Controller; sale only under a registered pharmacist's supervision for Schedule H drugs; conditions on premises area, cold storage, record retention.
• Schedules to remember: Schedule H — prescription-only; Schedule H1 — specified antibiotics, anti-TB and psychotropics requiring a separate bound register with prescriber and patient details, retained three years; Schedule X — narcotic/psychotropic items needing special licence and separate storage; Schedule G — "to be taken under medical supervision"; Schedule M — GMP for manufacturing premises (revised schedule M requirements apply to manufacturers); Schedule P — shelf life/storage conditions; Schedule F/F-1 — blood bank and biological requirements.
• Pharmacy Act, 1948 and Pharmacy Practice Regulations, 2015: only a person registered with the State Pharmacy Council may compound and dispense; registration renewal, display of registration certificate.
• NDPS Act, 1985 (amended 2014) and state rules: Recognised Medical Institution (RMI) route eases access to essential narcotic drugs (morphine etc.) for palliative care; strict register, indent, double lock, balance verification and destruction under authority.
• Drugs (Prices Control) Order, 2013 with NPPA: ceiling prices for scheduled formulations, annual WPI-linked revision, and a cap on price increase for non-scheduled drugs (10% in 12 months); NPPA has also capped margins on selected items — a hospital cannot charge above the printed ceiling/MRP.
• Other statutes touching the store: Clinical Establishments (Registration and Regulation) Act, 2010 in adopting states; Bio-Medical Waste Management Rules, 2016; Legal Metrology (packaged commodity declarations); AERB for radiation sources; Medical Devices Rules, 2017 (devices now regulated as drugs, licence Forms MD-41/42 for sale); Narcotics state rules; and the four Labour Codes in force from 21 November 2025 for store staff conditions.
• NABH (5th edition) MOM standards in essence: a documented formulary; safe storage with look-alike/high-alert/narcotic controls; prescription legibility and generic/standard abbreviations; dispensing by qualified staff with verification; drug-recall and near-expiry process; ADR reporting to the Pharmacovigilance Programme of India (PvPI) through an AMC; medication error reporting and analysis. NABH Chapter on Facility Management covers store safety.

Key points

• Materials management - integrated control of the whole material cycle to achieve the 5 Rs at least total cost.
• Share of budget - drugs and consumables are typically 25-40% of recurring hospital expense; the largest controllable spend.
• ABC analysis - by annual consumption value (A: ~10% items/70% value); drives how tightly an item is purchased and reviewed.
• VED analysis - by criticality to life; Vital items are never allowed to stock out, however cheap.
• ABC-VED matrix - Category I (AV, BV, CV, AE, AD) top-management control; Category II middle; Category III store-keeper.
• FSN and XYZ - FSN by movement (finds dead stock), XYZ by value of stock in hand (used at physical verification).
• EOQ - the order size where annual ordering cost equals annual carrying cost; valid only for steady demand and fixed price.
• Reorder level - average demand during lead time plus safety stock; triggers the next purchase order.
• FEFO - first expiry first out; for drugs it replaces FIFO because receipt order ≠ expiry order.
• Rate contract - pre-agreed price and terms; supply orders drawn as needed, cutting lead time and stockholding.
• GeM and state corporations - default procurement route for government hospitals (TNMSC, KSMSCL, RMSCL, CMSS).
• Form 20/21 and 20B/21B - retail and wholesale drug sale licences under the Drugs and Cosmetics Rules, 1945.
• Schedule H1 - separate three-year register for specified antibiotics, anti-TB and psychotropic drugs.
• NDPS double lock - narcotics in a safe under the registered pharmacist, with a running-balance register.
• Cold chain - +2 to +8 °C for vaccines, logged twice daily, with back-up power and VVM checks.
• Unit dose dispensing - 24-hour patient-wise packed doses; lowest medication error and wastage.
• DPCO 2013 / NPPA - ceiling prices on scheduled formulations; hospital billing cannot exceed them.
• Key indicators - inventory turnover ratio, stock-out rate, expiry as % of purchases, carrying cost as % of inventory value.

Formulas and examples

Example 1 — EOQ, orders and total cost. A 500-bed hospital consumes 36,000 vials of ceftriaxone 1 g a year at ₹25 per vial. Ordering cost is ₹500 per order; carrying cost is 20% of unit price per year.

• Cc = 0.20 × 25 = ₹5 per vial per year.
• EOQ = √(2 × 36,000 × 500 / 5) = √(36,000,000/5) = √7,200,000 ≈ 2,683 vials.
• Orders per year = 36,000 / 2,683 ≈ 13.4 (say 13-14); cycle ≈ 365/13.4 ≈ 27 days.
• Ordering cost = 13.4 × 500 ≈ ₹6,708; carrying cost = (2,683/2) × 5 ≈ ₹6,708 → total inventory cost ≈ ₹13,416 (the two are equal at EOQ — the standard check).
• If instead the hospital ordered monthly (3,000 vials): ordering = 12 × 500 = ₹6,000; carrying = 1,500 × 5 = ₹7,500; total = ₹13,500 — only ₹84 worse, showing the EOQ curve is flat near the optimum.

Example 2 — Reorder level, safety stock and maximum stock. Same item: average daily consumption 36,000/365 ≈ 98.6 vials; lead time 10 days; management wants 7 days' buffer.

• Safety stock = 98.6 × 7 ≈ 690 vials.
• ROL = (98.6 × 10) + 690 = 986 + 690 ≈ 1,676 vials.
• Maximum stock = ROL + EOQ − (minimum daily demand × minimum lead time). Taking minimum demand 80/day and minimum lead time 6 days: 1,676 + 2,683 − 480 ≈ 3,879 vials.
• Average inventory = EOQ/2 + safety stock = 1,342 + 690 = 2,032 vials ≈ ₹50,800 locked up.

Example 3 — ABC analysis. Five pharmacy items, annual consumption value:

Total = ₹70,00,000. Two items (40% of the list) carry 75% of value → A class, reviewed weekly with a negotiated rate contract; paracetamol is C class, bought in bulk twice a year. Note paracetamol is only C by value but E by criticality, so the ABC-VED matrix places it in Category II (a C item that is V, such as adrenaline, would fall in Category I) with a healthy buffer — it must never run out.

Example 4 — Inventory turnover and expiry loss. A pharmacy's annual drug consumption is ₹9.6 crore; opening inventory ₹95 lakh, closing ₹1.05 crore. Expired stock destroyed in the year: ₹14.4 lakh of purchases worth ₹9.8 crore.

• Average inventory = (95 + 105)/2 = ₹100 lakh = ₹1 crore.
• ITR = 9.6 / 1.0 = 9.6 times a year → days of stock = 365/9.6 ≈ 38 days.
• Expiry loss = 14.4 / 980 = 1.47% of purchase value — above the commonly used internal benchmark of under 1%, pointing to weak FEFO, over-ordering of A items or non-moving (N in FSN) stock.
• Raising ITR to 14 would cut average inventory to 9.6/14 ≈ ₹68.6 lakh, releasing about ₹31.4 lakh of working capital and saving ≈ 20% × 31.4 ≈ ₹6.3 lakh a year in carrying cost — but only if safety stock on Vital items is untouched.

Example 5 — Buy versus rate-contract-with-JIT for an implant. A hospital uses 240 drug-eluting stents a year at ₹35,000 each (NPPA-capped category). Option A: buy in lots of 60 (ordering cost ₹2,000, carrying 18%/yr). Option B: consignment stock from the vendor, paid on use, with ₹1,20,000 a year of administrative and verification cost.

• Option A: average inventory = 30 stents = ₹10,50,000 → carrying = 0.18 × 10,50,000 = ₹1,89,000; ordering = 4 × 2,000 = ₹8,000; total = ₹1,97,000, plus expiry and model-obsolescence risk on the hospital.
• Option B: ₹1,20,000, with the expiry and obsolescence risk on the vendor.
• Consignment is cheaper by ₹77,000 a year and shifts risk — the usual reason Indian hospitals keep implants, high-end reagents and ortho trays on consignment.

Where it is used

• Hospital purchase and stores departments — Materials Manager, Purchase Officer, Store Keeper, Inventory Analyst roles in Apollo, Fortis, Max, Manipal, Narayana Health, AIIMS and state medical colleges.
• Pharmacy operations — Chief Pharmacist, pharmacy in-charge, clinical pharmacist and pharmacy audit roles; retail chains and hospital-linked pharmacies (Apollo Pharmacy, MedPlus, Wellness Forever) use the same ABC/FSN and expiry controls.
• Government supply chains — TNMSC, KSMSCL, RMSCL, CMSS, CGHS and ESIC run rate contracts, warehouse networks and drug distribution software (e.g. Tamil Nadu's passbook system, DVDMS in central institutions); Jan Aushadhi/PMBJP stores.
• Insurance and scheme costing — AB-PMJAY and CGHS package rates force consumable standardisation and cost-per-case control; materials data feeds the costing.
• Quality and accreditation — NABH/JCI assessment of medication management, cold chain, high-alert and narcotic storage; internal audits on expiry, recall drill and crash-cart checks.
• HIS/ERP implementation — consultants and product teams configuring inventory, indent, batch-expiry and GST modules in hospital software.

Interview questions

• Q: Differentiate ABC and VED analysis. A: ABC classifies items by annual consumption value to decide purchase and control effort; VED classifies by criticality to the patient, so a cheap but vital drug like adrenaline gets a full buffer even though it is a C item by value.
• Q: Why is FEFO preferred over FIFO in a drug store? A: Batches received earlier may have a later expiry date, so issuing strictly by receipt order can leave short-dated stock behind; FEFO issues the earliest-expiring batch and minimises expiry loss.
• Q: What are the assumptions behind EOQ and why does it fail in hospitals? A: It assumes constant known demand, fixed unit price, instantaneous replenishment and no stock-out cost; hospital demand is erratic, prices are tiered, and the real cost of a stock-out of a vital drug is clinical, not financial.
• Q: A vital drug ran out twice last month. What do you do? A: Check consumption trend against ROL and lead time, recompute safety stock, verify whether the indent or the supplier failed, put the item on rate contract with an alternate vendor, and move it into Category I review.
• Q: What licences must a hospital pharmacy hold? A: Retail sale licence in Form 20/21 (and 20B/21B if it supplies other institutions) under the Drugs and Cosmetics Rules, 1945, with a pharmacist registered under the Pharmacy Act, 1948 in charge, plus Schedule X / NDPS authorisation for narcotics and MD-42 for medical devices.
• Q: How are Schedule H1 drugs handled differently? A: They must be sold against prescription and entered in a separate bound register with the prescriber's and patient's details and the drug and quantity, kept for three years, and the pack carries the H1 warning box.
• Q: How do you control narcotics in a hospital? A: Double-locked substantial safe with keys held by the registered pharmacist, a dedicated NDPS register with running balance, issue only against a prescriber's requisition, shift-wise balance verification, empty ampoule return, and destruction only under the prescribed authority.
• Q: What is unit dose dispensing and what are its drawbacks? A: The pharmacy supplies each dose individually packed and labelled for the next 24 hours, which cuts medication errors, pilferage and wastage; it needs more pharmacist time, repacking space, software and so has a higher running cost.
• Q: How would you reduce inventory without risking availability? A: Attack the A and FSN-N items — shorter, more frequent orders on rate contract, consignment stock for implants and reagents, formulary pruning of duplicate brands — while leaving Vital-item safety stock intact, and track stock-out rate alongside inventory turnover.
• Q: A high ITR with a high stock-out rate — what does it mean? A: Inventory is being squeezed below safe levels; turnover looks good only because safety stock has been cut, so the two indicators must always be read together.
• Q: How does a drug recall work in a hospital? A: On the manufacturer's or regulator's notice, the batch number is traced through GRN, stock ledger and dispensing records to wards and patients, stock is quarantined with a "not for use" tag, patients and prescribers are informed, and the return and replacement are documented — a NABH requirement.
• Q: What is a rate contract and how does it differ from a purchase order? A: A rate contract fixes price, specification and terms for a period without committing a quantity; a purchase order is the actual commitment to buy a stated quantity, drawn against that contract or a fresh tender.
• Q: Where do expired medicines go? A: They are quarantined, recorded, and disposed of under the Bio-Medical Waste Management Rules, 2016 — yellow-category handling through the common bio-medical waste treatment facility, or return to the manufacturer where the contract allows — never into general municipal waste.

Common mistakes

• Treating EOQ as the answer to every inventory question and ignoring stock-out cost, tiered pricing, shelf life and minimum order quantity set by the supplier.
• Writing ROL without safety stock, or mixing units — monthly demand with lead time in days — which is the commonest arithmetic slip in exams.
• Confusing ABC with VED (value with criticality), or stating ABC percentages as a fixed rule rather than a convention.
• Classifying by value of stock in hand and calling it ABC — that is XYZ analysis.
• Saying FIFO for drugs, and forgetting that expiry, not receipt date, decides the issue order.
• Quoting drug licence forms loosely — Form 20/21 is retail, 20B/21B wholesale; confusing Schedule H with H1 or X.
• Reporting a lower inventory value as an achievement without reporting the stock-out rate and expiry loss alongside it.

Related topics

Hospital support services: CSSD, laundry, dietary, housekeeping and biomedical engineering · Biomedical waste management · Hospital information systems and digital health (ABDM and ABHA) · Hospital financial management and costing · NABH accreditation and quality assurance · Drug store and pharmacy law (Drugs and Cosmetics Act).